[Surgery, inflammatory bowel disease and biological treatment]

Tidsskr Nor Laegeforen. 2009 Nov 19;129(22):2389-90. doi: 10.4045/tidsskr.09.1231.
[Article in Norwegian]
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / adverse effects
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects
  • Colectomy / adverse effects
  • Colitis, Ulcerative / drug therapy
  • Colitis, Ulcerative / surgery*
  • Crohn Disease / drug therapy
  • Crohn Disease / surgery*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Infliximab
  • Prednisolone / administration & dosage
  • Prednisolone / adverse effects
  • Risk Factors
  • Surgical Wound Infection / etiology*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Prednisolone
  • Infliximab